PURPOSE: To describe the phenotype and genotype of patients with autosomal recessive bestrophinopathy. METHODOLOGY: The phenotype of the subjects was described after a complete ophthalmological examination, and in various cases, ancillary testing of the visual field, optical coherent tomography, full field electroretinography and electrophysiology. Genetic analysis was carried out by screening the Bestrophin-1 (BEST1) gene for mutations by dideoxy sequencing and segregation analysis. RESULTS: We identified three previously described mutations (Ala195Val, Leu191Pro and Arg141His) and two potentially pathogenic changes (Trp93Pro and Trp287Ter) in the Best-1 gene. Two patients carried compound heterozygous mutations, Trp93Pro/Ala195Val, and Leu191Pro/Trp287Ter. Two sisters were homozygous for an Arg141His mutation. All individuals with Best1 gene mutations had signs of maculopathy. CONCLUSIONS: Our observations expand the limited number of phenotypes associated with mutations in the Best1 gene. Patients with compound heteroyzygous Best1 mutations developed atypical forms of Best disease. Two siblings with homozygous Arg141His mutation developed symptoms of typical Best vitelliform dystrophy while their parents had clinical features of mild maculopathy.
PURPOSE: To describe the phenotype and genotype of patients with autosomal recessive bestrophinopathy. METHODOLOGY: The phenotype of the subjects was described after a complete ophthalmological examination, and in various cases, ancillary testing of the visual field, optical coherent tomography, full field electroretinography and electrophysiology. Genetic analysis was carried out by screening the Bestrophin-1 (BEST1) gene for mutations by dideoxy sequencing and segregation analysis. RESULTS: We identified three previously described mutations (Ala195Val, Leu191Pro and Arg141His) and two potentially pathogenic changes (Trp93Pro and Trp287Ter) in the Best-1 gene. Two patients carried compound heterozygous mutations, Trp93Pro/Ala195Val, and Leu191Pro/Trp287Ter. Two sisters were homozygous for an Arg141His mutation. All individuals with Best1 gene mutations had signs of maculopathy. CONCLUSIONS: Our observations expand the limited number of phenotypes associated with mutations in the Best1 gene. Patients with compound heteroyzygous Best1 mutations developed atypical forms of Best disease. Two siblings with homozygous Arg141His mutation developed symptoms of typical Best vitelliform dystrophy while their parents had clinical features of mild maculopathy.
Authors: Pooja Biswas; Jacque L Duncan; Bruno Maranhao; Igor Kozak; Kari Branham; Luis Gabriel; Jonathan H Lin; Giulio Barteselli; Mili Navani; John Suk; Michelle Parke; Catherine Schlechter; Richard G Weleber; John R Heckenlively; Gislin Dagnelie; Pauline Lee; S Amer Riazuddin; Radha Ayyagari Journal: Physiol Genomics Date: 2017-01-27 Impact factor: 3.107
Authors: Karina E Guziewicz; Divya Sinha; Néstor M Gómez; Kathryn Zorych; Emily V Dutrow; Anuradha Dhingra; Robert F Mullins; Edwin M Stone; David M Gamm; Kathleen Boesze-Battaglia; Gustavo D Aguirre Journal: Prog Retin Eye Res Date: 2017-01-19 Impact factor: 21.198
Authors: Mital Shah; Suzanne Broadgate; Morag Shanks; Penny Clouston; Jing Yu; Robert E MacLaren; Andrea H Németh; Stephanie Halford; Susan M Downes Journal: JAMA Ophthalmol Date: 2020-05-01 Impact factor: 7.389
Authors: Amit Tiwari; Johannes Lemke; Janine Altmueller; Holger Thiele; Esther Glaus; Johannes Fleischhauer; Peter Nürnberg; John Neidhardt; Wolfgang Berger Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240
Authors: Catherine Cukras; Terry Gaasterland; Pauline Lee; Harini V Gudiseva; Venkata R M Chavali; Raghu Pullakhandam; Bruno Maranhao; Lee Edsall; Sandra Soares; G Bhanuprakash Reddy; Paul A Sieving; Radha Ayyagari Journal: PLoS One Date: 2012-11-26 Impact factor: 3.240